Roche Diagnostics cobas e 601 Analyzer (14867)
Specialty: Endocrinology
Welcome to the PulseAid listing for the Roche Diagnostics cobas e 601 Analyzer medical device. This device is used in the Endocrinology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the Endocrinology healthcare specialty at the bottom of the page.
Analytes Measured/Detected and Complexity:
| ANALYTE | COMPLEXITY |
| 25-hydroxyvitamin D (25-OH-D) (K113546 | K113546) | MODERATE Effective Date: 2012-08-27 |
| Adrenocorticotropic hormone (ACTH) (K060585 | K060585) | MODERATE Effective Date: 2011-01-20 |
| Alpha-fetoprotein – tumor marker (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Anti-citrullinated cyclic peptide (Anti-CCP) (K081338 | K081338) | MODERATE Effective Date: 2008-09-12 |
| Anti-Mullerian Hormone (AMH) (CR170044 | DEN150057) | MODERATE Effective Date: 2017-02-24 |
| Anti-thyroglobulin antibodies (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Anti-thyroid peroxidase (TPO) antibodies (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| B-type natriuretic peptide (BNP) (K072437 | K072437) | MODERATE Effective Date: 2008-02-07 |
| C-peptide (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| CA 19-9 (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Calcitonin (K132828 | K132828) | MODERATE Effective Date: 2014-02-07 |
| Cancer antigen 125 (CA 125) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Cancer antigen 15-3 (CA 15-3) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Cancer antigen, cytokeratin fragments 21-1 (CR160725 | K160915) | MODERATE Effective Date: 2017-01-18 |
| Carcinoembryonic antigen (CEA) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Collagen type I, C-telopeptides (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Cortisol (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Creatine kinase MB fraction (CKMB) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Cytomegalovirus (CR150068 | K142133) | MODERATE Effective Date: 2015-02-20 |
| Dehydroepiandrosterone sulfate (DHEA-SO4) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Digoxin (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Estradiol (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Ferritin (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Folate (folic acid) (K082340 | K082340) | MODERATE Effective Date: 2009-11-09 |
| Folate, red blood cell (RBC folate) (K103716 | K103716) | HIGH Effective Date: 2011-06-02 |
| Follicle stimulating hormone (FSH) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| hCG, beta, serum, quantitative (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| hCG, total, serum, quantitative (K002148 | K002148) | MODERATE Effective Date: 2010-06-18 |
| Hepatitis A virus antibody (K100903 | K100903) | MODERATE Effective Date: 2010-10-26 |
| Hepatitis B core antibody (CR160489 | P110022/S019) | MODERATE Effective Date: 2017-03-10 |
| Human growth hormone (GH) (X110020 | X110020) | MODERATE Effective Date: 2011-06-14 |
| Immunoglobulins IgE (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Insulin (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Luteinizing hormone (LH) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Myoglobin (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| N-Terminal pro brain natriuretic peptide (ProBNP) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Osteocalcin (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Parathyroid hormone – intact (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Progesterone (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Prolactin (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Prostatic specific antigen (PSA) (P990056 | P990056/S008) | MODERATE Effective Date: 2008-12-03 |
| Prostatic specific antigen (PSA), free (P000027 | P000027/S006) | MODERATE Effective Date: 2008-11-13 |
| Sex hormone binding globulin (K102814 | K102814) | MODERATE Effective Date: 2011-01-24 |
| T uptake (TU) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Testosterone (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Thyroid stimulating hormone (TSH) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Thyroxine (T4) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Thyroxine, free (FT4) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Triiodothyronine (T3) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Triiodothyronine, free (FT3) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Troponin T (Tn T) (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |
| Troponin-I (cardiac) (K082699 | K082699) | MODERATE Effective Date: 2009-09-22 |
| TSH receptor antibody (K080092 | K080092) | MODERATE Effective Date: 2008-07-30 |
| Vitamin B12 (K060373 | K060373) | MODERATE Effective Date: 2006-03-16 |